BaseLaunch Accelerator (Basel)

https://www.baselaunch.ch

LinkedIn: https://www.linkedin.com/company/baselaunch

BaseLaunch, an initiative of BaselArea.swiss, works to attract and accelerate promising and groundbreaking healthcare startups and strengthen the Basel region’s position as leading life sciences hub. The accelerator program provides participating teams with infusions of funds, insight, infrastructure and industry access, and integrates them into one of the most dynamic biotech and pharma ecosystems in Europe. BaseLaunch is supported by healthcare partners Novartis Venture Fund, Johnson & Johnson Innovation and Pfizer as well as other public and private partners. Applications are vetted by a selection committee consisting of Dr. Fabian Buller, Director New Ventures, Johnson & Johnson Innovation, Dr. Phillipe Dro, CEO, NeMoDevices, Trudi Haemmerli, CEO and Director, PerioC Ltd, Managing Director, TruStep Consulting GmbH, Dr. Anja König, Managing Director, Novartis Venture Fund, Dr. Alex Mayweg, Venture Partner, Versant Ventures and Dr. Nathalie ter Wengel MD, European Head External R&D and Innovation, Pfizer. *

	Start	2017-02-22 established
	Group	Basel (govt city)
	Industry	business park management / science park management
	Industry 2	LIFE SCIENCES
	Person	de Léon, Alethia (Basel (govt) 201702 Managing Director of BaseLaunch)

	Region	Basel BS
	Country	Switzerland
	Street	11 Dufourstr.
	City	4052 Basel
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: BaseLaunch (BaselArea.swiss). (5/15/20). "Press Release: Roche Becomes Founding Partner of BaseLaunch Phase II". Basel.

		Record changed: 2023-07-10